|
|
|
|
|
|
|
|
|
|
abstract
Results: Of 246 patients, 130 underwent restaging surgery and 116 received chemotherapy only. Follow-up duration ranged from 4 to 148 months (median, 72 months). The 5-year overall survival (OS) rates were 87.5% and 74.7% in the restaging and chemotherapy groups, respectively.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.